1. Home
  2. DBD vs EXPO Comparison

DBD vs EXPO Comparison

Compare DBD & EXPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diebold Nixdorf Incorporated

DBD

Diebold Nixdorf Incorporated

HOLD

Current Price

$89.21

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$61.44

Market Cap

3.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DBD
EXPO
Founded
1859
1967
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Professional Services
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
DBD
EXPO
Price
$89.21
$61.44
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$90.00
$88.00
AVG Volume (30 Days)
255.9K
524.3K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
1.87%
EPS Growth
677.27
N/A
EPS
0.14
0.59
Revenue
$3,805,700,000.00
$582,014,000.00
Revenue This Year
$3.56
$12.75
Revenue Next Year
$3.25
$8.50
P/E Ratio
$621.29
$101.66
Revenue Growth
1.46
4.21
52 Week Low
$53.93
$51.91
52 Week High
$89.05
$81.95

Technical Indicators

Market Signals
Indicator
DBD
EXPO
Relative Strength Index (RSI) 67.21 53.12
Support Level $82.06 $54.15
Resistance Level N/A $69.49
Average True Range (ATR) 2.69 1.94
MACD 0.22 -0.20
Stochastic Oscillator 91.19 37.89

Price Performance

Historical Comparison
DBD
EXPO

About DBD Diebold Nixdorf Incorporated

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment.

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

Share on Social Networks: